M Lemm

901 total citations
25 papers, 730 citations indexed

About

M Lemm is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, M Lemm has authored 25 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Immunology. Recurrent topics in M Lemm's work include RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (4 papers) and S100 Proteins and Annexins (4 papers). M Lemm is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (4 papers) and S100 Proteins and Annexins (4 papers). M Lemm collaborates with scholars based in Germany, United States and Russia. M Lemm's co-authors include Iduna Fichtner, Ulrike Stein, Wolfgang Walther, Ulrike Sack, Dennis Kobelt, Robert H. Shoemaker, P. M. Schlag, Dominic A. Scudiero, Enrique Montero and Janice Smith and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Oncogene.

In The Last Decade

M Lemm

25 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Lemm Germany 13 437 219 124 94 84 25 730
John W. Madsen United States 10 469 1.1× 89 0.4× 160 1.3× 140 1.5× 105 1.3× 11 791
Sharon Glaysher United Kingdom 16 324 0.7× 286 1.3× 112 0.9× 54 0.6× 143 1.7× 30 690
Kylie A. Hotchkiss United States 12 622 1.4× 224 1.0× 169 1.4× 136 1.4× 115 1.4× 13 1.0k
Saiful Effendi Syafruddin Malaysia 16 593 1.4× 199 0.9× 253 2.0× 146 1.6× 102 1.2× 40 992
Haozhe Piao China 18 435 1.0× 179 0.8× 221 1.8× 100 1.1× 101 1.2× 54 791
Chirayu Patel United States 8 331 0.8× 346 1.6× 174 1.4× 63 0.7× 56 0.7× 12 696
Patrick Maier Germany 16 417 1.0× 263 1.2× 154 1.2× 111 1.2× 140 1.7× 31 889
Vanessa Baeriswyl Switzerland 12 728 1.7× 452 2.1× 190 1.5× 150 1.6× 73 0.9× 14 1.1k
Almer M. van der Sloot Spain 20 848 1.9× 186 0.8× 94 0.8× 210 2.2× 48 0.6× 36 1.1k
Junko Kano Japan 19 527 1.2× 163 0.7× 201 1.6× 103 1.1× 98 1.2× 46 920

Countries citing papers authored by M Lemm

Since Specialization
Citations

This map shows the geographic impact of M Lemm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Lemm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Lemm more than expected).

Fields of papers citing papers by M Lemm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Lemm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Lemm. The network helps show where M Lemm may publish in the future.

Co-authorship network of co-authors of M Lemm

This figure shows the co-authorship network connecting the top 25 collaborators of M Lemm. A scholar is included among the top collaborators of M Lemm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Lemm. M Lemm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huska, Matthew R., Miguel A. Andrade‐Navarro, M Lemm, et al.. (2015). SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival. Oncogene. 35(46). 5942–5952. 54 indexed citations
2.
Kobelt, Dennis, Jutta Aumann, Manuel Schmidt, et al.. (2014). Preclinical study on combined chemo‐ and nonviral gene therapy for sensitization of melanoma using a human TNF‐alpha expressing MIDGE DNA vector. Molecular Oncology. 8(3). 609–619. 11 indexed citations
3.
Zeisig, Reiner, et al.. (2012). Treatment of Experimental Brain Metastasis with MTO-Liposomes: Impact of Fluidity and LRP-Targeting on the Therapeutic Result. Pharmaceutical Research. 29(7). 1949–1959. 26 indexed citations
4.
Walther, Wolfgang, Olga N. Kuvardina, Jutta Aumann, et al.. (2011). Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors. Gene Therapy. 19(5). 494–503. 58 indexed citations
5.
Sack, Ulrike, Wolfgang Walther, Dominic A. Scudiero, et al.. (2011). Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer. JNCI Journal of the National Cancer Institute. 103(13). 1018–1036. 171 indexed citations
6.
Stein, Ulrike, Franziska Arlt, Janice Smith, et al.. (2011). Intervening in β-Catenin Signaling by Sulindac Inhibits S100A4-Dependent Colon Cancer Metastasis. Neoplasia. 13(2). 131–IN8. 76 indexed citations
7.
Rolff, Jana, et al.. (2009). Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies. British Journal of Cancer. 100(6). 950–958. 68 indexed citations
8.
Zeisig, Reiner, Tilen Koklič, Marjeta Šentjurc, et al.. (2009). Impact of membrane properties on uptake and transcytosis of colloidal nanocarriers across an epithelial cell barrier model. Journal of Pharmaceutical Sciences. 99(5). 2423–2433. 23 indexed citations
9.
Hoffmann, Jens, Iduna Fichtner, M Lemm, et al.. (2008). Sagopilone crosses the blood–brain barrier in vivo to inhibit brain tumor growth and metastases. Neuro-Oncology. 11(2). 158–166. 60 indexed citations
10.
Kisseleva, Е. P., et al.. (2002). Early macrophage and cytokine response during the growth of immunogenic and non-immunogenic murine tumors.. PubMed. 21(5). 3477–84. 4 indexed citations
11.
Walther, Wolfgang, et al.. (2001). Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Therapy. 8(3). 173–180. 50 indexed citations
12.
Lemm, M, et al.. (1999). Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.. PubMed. 19(3A). 1977–87. 1 indexed citations
13.
Stein, Ulrike, Wolfgang Walther, M Lemm, H Naundorf, & Iduna Fichtner. (1997). Development and characterisation of novel human multidrug resistant mammary carcinoma linesin vitro andin vivo. International Journal of Cancer. 72(5). 885–891. 33 indexed citations
14.
Fichtner, Iduna, M Lemm, Matthias Becker, & Frank Berthold. (1997). Effects of amifostine (WR-2721, ethyol) on tumor growth and pharmacology of cytotoxic drugs in human xenotransplanted neuroblastomas. Anti-Cancer Drugs. 8(2). 174–181. 16 indexed citations
15.
Fichtner, Iduna, et al.. (1994). Stimulation of Hematopoiesis by Carboplatin-Liposomes. Journal of Liposome Research. 4(1). 43–69. 3 indexed citations
16.
Fichtner, Iduna, Regina Reszka, Michael C. Rudolph, et al.. (1993). Carboplatin-liposomes as activators of hematopoiesis.. PubMed. 5(2). 65–74. 5 indexed citations
17.
Fichtner, Iduna, et al.. (1993). In vivo characterization of immunogenicity of a mitoxantrone-resistant murine P388 leukemia.. PubMed. 7(1). 73–9. 1 indexed citations
18.
Fichtner, Iduna, et al.. (1992). In vivodistribution and antitumour activity of liposomal 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine. Journal of Microencapsulation. 9(3). 335–346. 12 indexed citations
19.
Fichtner, Iduna, et al.. (1990). Development of a Mitoxantrone-Resistant P 388 in vivo: Approaches to Overcome Resistance. Oncology. 47(6). 508–515. 1 indexed citations
20.
Fichtner, Iduna, et al.. (1990). Determination of antineoplastic activity and toxicity of tumor necrosis factor (TNF) in animal experiments. Correlation to clinical findings.. PubMed. 37(3). 301–15. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026